Home Newsfeeds Morgan Stanley Downgrades Edison to Underweight, Announces $62 Price Target

Morgan Stanley Downgrades Edison to Underweight, Announces $62 Price Target

Morgan Stanley analyst David Arcaro downgrades Edison (NYSE:EIX) from Equal-Weight to Underweight and announces $62 price target.

byBenzinga Newsdesk

September 6, 2022

1 minute read

Morgan Stanley analyst David Arcaro downgrades Edison (NYSE:EIX) from Equal-Weight to Underweight and announces $62 price target.

HC Wainwright & Co. Initiates Coverage On Blue Water Vaccines with Buy Rating, Announces Price Target of $7

By Benzinga Newsdesk

December 9, 7:11 AM

HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Blue Water Vaccines (NASDAQ:BWV) with a Buy rating and announces Price Target of $7.

BWV

Acadia Pharmaceuticals Announces Label Update for NUPLAZID; U.S. FDA Revises Boxed Warning To Clarify That Nuplazid Can Be Used To Treat Patients With Parkinson’s Disease-Related Hallucinations And Delusions Who Also Have Dementia

By Benzinga Newsdesk

September 18, 11:20 AM

— U.S. FDA revises Boxed Warning to clarify that NUPLAZID can be used to treat patients with Parkinson's disease-related hallucinations and delusions who also have dementiaSAN DIEGO — September 18, 2023 – Acadia

ACAD